BCG vaccine--current status.
J Indian Med Assoc
;
2000 Mar; 98(3): 110-1, 114
Artículo
en Inglés
| IMSEAR
| ID: sea-103424
ABSTRACT
Tuberculosis incidence has made re-emergence due to multidrug resistance of the bacilli and for acquired immunodeficiency syndrome. Of all vaccines BCG is most widely used. It protects children from secondary forms of tuberculosis. Several authors recommend a second dose to boost the waning effect of BCG. The vaccine at present needs to be improved to make it more efficacious. Vaccines which involve the protective immune responses are ideal.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Tuberculosis Pulmonar
/
Humanos
/
Prueba de Tuberculina
/
Vacuna BCG
/
Niño
/
Esquemas de Inmunización
/
Inmunización Secundaria
/
India
País/Región como asunto:
Asia
Idioma:
Inglés
Revista:
J Indian Med Assoc
Año:
2000
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS